載入...

Generation and evaluation of a monoclonal antibody, designated MAdL, as a new specific marker for adenocarcinomas of the lung

BACKGROUND: Different therapy regimens in non-small-cell lung cancer (NSCLC) are of rising clinical importance, and therefore a clear-cut subdifferentiation is mandatory. The common immunohistochemical markers available today are well applicable for subdifferentiation, but a fraction of indistinct c...

全面介紹

Na minha lista:
書目詳細資料
Main Authors: Schultz, H, Marwitz, S, Baron-Lühr, B, Zissel, G, Kugler, C, Rabe, K F, Zabel, P, Vollmer, E, Gerdes, J, Goldmann, T
格式: Artigo
語言:Inglês
出版: Nature Publishing Group 2011
主題:
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC3188931/
https://ncbi.nlm.nih.gov/pubmed/21811254
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bjc.2011.281
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!